Related Experiment Video
Updated: Jul 2, 2025
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors
Cosima C Hoch1, Leonard Knoedler2,3, Samuel Knoedler4
1Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich (TUM), Ismaningerstrasse 22, 81675, Munich, Germany.
Purpose Of Review:
This review aims to provide a comprehensive overview of mesenchymal sinonasal tract tumors (STTs), a distinct subset of STTs. Despite their rarity, mesenchymal STTs represent a unique clinical challenge, characterized by their rarity, often slow progression, and frequently subtle or overlooked symptoms. The complex anatomy of the sinonasal area, which includes critical structures such as the orbit, brain, and cranial nerves, further complicates surgical treatment options. This underscores an urgent need for more advanced and specialized therapeutic approaches.
Recent Findings:
Advancements in molecular diagnostics, particularly in next-generation sequencing, have significantly enhanced our understanding of STTs. Consequently, the World Health Organization has updated its tumor classification to better reflect the distinct histological and molecular profiles of these tumors, as well as to categorize mesenchymal STTs with greater accuracy. The growing understanding of the molecular characteristics of mesenchymal STTs opens new possibilities for targeted therapeutic interventions, marking a significant shift in treatment paradigms. This review article concentrates on mesenchymal STTs, specifically addressing sinonasal tract angiofibroma, sinonasal glomangiopericytoma, biphenotypic sinonasal sarcoma, and skull base chordoma. These entities are marked by unique histopathological and molecular features, which challenge conventional treatment approaches and simultaneously open avenues for novel targeted therapies. Our discussion is geared towards delineating the molecular underpinnings of mesenchymal STTs, with the objective of enhancing therapeutic strategies and addressing the existing shortcomings in the management of these intricate tumors.
Insights
Mesenchymal sinonasal tract tumors (STTs) are rare and challenging to treat due to complex anatomy. Advances in molecular diagnostics are improving classification and paving the way for targeted therapies for these intricate tumors.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Mesenchymal sinonasal tract tumors (STTs) are a rare and distinct subset of sinonasal tumors.
- Their rarity, slow progression, and subtle symptoms present diagnostic and therapeutic challenges.
- The intricate sinonasal anatomy complicates surgical interventions, necessitating advanced treatment strategies.
Purpose of the Study:
- To provide a comprehensive overview of mesenchymal sinonasal tract tumors (STTs).
- To highlight advancements in molecular diagnostics and their impact on tumor classification.
- To explore novel therapeutic approaches based on molecular understanding.
Main Methods:
- Review of current literature on mesenchymal sinonasal tract tumors.
- Analysis of updated World Health Organization (WHO) tumor classifications.
- Focus on molecular diagnostics and next-generation sequencing (NGS) findings.
Main Results:
- Molecular diagnostics have significantly improved the understanding and classification of STTs.
- The WHO classification now better reflects distinct histological and molecular profiles.
- Understanding molecular characteristics opens avenues for targeted therapeutic interventions.
Conclusions:
- Mesenchymal STTs require specialized therapeutic approaches.
- Molecular insights are crucial for developing targeted therapies.
- Further research into the molecular underpinnings of these tumors is essential for improved management.
